Literature DB >> 19095028

Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination.

Suzanne E Ohmit1, Jonathan Gross, John C Victor, Arnold S Monto.   

Abstract

Data collected as part of a multi-year trial examining the efficacies of inactivated and live-attenuated influenza vaccines were used to evaluate the reported occurrence of post-vaccination reactions. Two cohorts were defined: (1) individuals who received the same vaccine over two consecutive years, and (2) individuals who first enrolled in year 2 of the study and received vaccine only in that year. For both vaccines there were significantly fewer reactions reported in year 2 in those subjects who were vaccinated both years. Declines were demonstrated when comparing year 1 and 2 reaction frequencies in subjects vaccinated both years, and differences were seen when comparing year 2 reaction frequencies in subjects vaccinated both years with those first vaccinated in year 2. Reaction reporting peaked on post-vaccination days 0 and 1 following receipt of the inactivated vaccine, and on day 2 following receipt of the live-attenuated vaccine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095028      PMCID: PMC2665993          DOI: 10.1016/j.vaccine.2008.11.100

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.

Authors:  R B Belshe; W C Gruber
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Influenza vaccination. Knowledge, attitudes, and behavior among high-risk outpatients.

Authors:  K L Nichol; R P Lofgren; J Gapinski
Journal:  Arch Intern Med       Date:  1992-01

3.  Comparative trial of influenza vaccines. II. Adverse reactions in children and adults.

Authors:  D W Barry; R E Mayner; H D Hochstein; R C Dunlap; S C Rastogi; J E Hannah; R J Blackburn; J L Sullivan; R J Gerety
Journal:  Am J Epidemiol       Date:  1976-07       Impact factor: 4.897

4.  A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.

Authors:  K M Edwards; W D Dupont; M K Westrich; W D Plummer; P S Palmer; P F Wright
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

5.  A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

Authors:  Weigong Zhou; Vitali Pool; Frank DeStefano; John K Iskander; Penina Haber; Robert T Chen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-08       Impact factor: 2.890

6.  Patient acceptance of influenza vaccination.

Authors:  N H Fiebach; C M Viscoli
Journal:  Am J Med       Date:  1991-10       Impact factor: 4.965

7.  Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.

Authors:  Robert B Belshe; Kristin L Nichol; Steven B Black; Henry Shinefield; Julie Cordova; Robert Walker; Colin Hessel; Iksung Cho; Paul M Mendelman
Journal:  Clin Infect Dis       Date:  2004-09-07       Impact factor: 9.079

8.  Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines.

Authors:  Suzanne E Ohmit; John C Victor; Esther R Teich; Rachel K Truscon; Judy R Rotthoff; Duane W Newton; Sarah A Campbell; Matthew L Boulton; Arnold S Monto
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

9.  Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.

Authors:  T M Govaert; G J Dinant; K Aretz; N Masurel; M J Sprenger; J A Knottnerus
Journal:  BMJ       Date:  1993-10-16

10.  Risk of anaphylaxis after vaccination of children and adolescents.

Authors:  Kari Bohlke; Robert L Davis; S M Marcy; M M Braun; Frank DeStefano; Steven B Black; John P Mullooly; Robert S Thompson
Journal:  Pediatrics       Date:  2003-10       Impact factor: 7.124

View more
  5 in total

1.  Evaluation of multivalent H2 influenza pandemic vaccines in mice.

Authors:  Brian J Lenny; Stephanie Sonnberg; Angela F Danner; Kimberly Friedman; Richard J Webby; Robert G Webster; Jeremy C Jones
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 3.641

2.  Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.

Authors:  L E Davidson; A-M Fiorino; D R Snydman; P L Hibberd
Journal:  Eur J Clin Nutr       Date:  2011-02-02       Impact factor: 4.016

3.  Safety of a Trivalent Inactivated Influenza Vaccine in Health Care Workers in Kurdistan Province, Western Iran; A Longitudinal Follow-up Study.

Authors:  Jafar Soltani; Mohamad Jamil Amjadi
Journal:  Iran J Med Sci       Date:  2014-03

4.  The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial.

Authors:  Barnaby Young; Sapna Sadarangani; Haur Sen Yew; Chee Fu Yung; Yee Sin Leo; Mark I-Cheng Chen; Annelies Wilder-Smith
Journal:  Trials       Date:  2017-02-10       Impact factor: 2.279

Review 5.  Options and obstacles for designing a universal influenza vaccine.

Authors:  Yo Han Jang; Baik Lin Seong
Journal:  Viruses       Date:  2014-08-18       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.